Whan In Pharm Co.,Ltd.
KSC: 016580.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wonbum Lee
- Employees
- 582
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩172.2B
- Website
- https://www.whanin.com
Loading 016580…
Loading profile data…Frequently asked questions about 016580
What does Whan In Pharm Co.,Ltd. (016580.KS) do?
Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic...
Where does 016580.KS trade?
Whan In Pharm Co.,Ltd. (016580.KS) trades on the Korea Exchange.
What sector is 016580.KS in?
Whan In Pharm Co.,Ltd. (016580.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Whan In Pharm Co.,Ltd.?
Wonbum Lee is the chief executive officer of Whan In Pharm Co.,Ltd. (016580.KS).
Where is Whan In Pharm Co.,Ltd. headquartered?
Whan In Pharm Co.,Ltd. is headquartered in South Korea.
Does 016580.KS pay a dividend?
Yes — Whan In Pharm Co.,Ltd. (016580.KS) paid a trailing twelve-month dividend of KRW 300.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 016580.KS go public?
Whan In Pharm Co.,Ltd. (016580.KS) completed its initial public offering in 2000.